Literature DB >> 32444531

Usefulness of whole blood viscosity estimated by de Simeone's formula to predict left ventricular thrombus formation within one year following acute anterior myocardial infarction.

Ömer Faruk Çırakoğlu1, Ahmet Oguz Aslan2, Ahmet Seyda Yilmaz3, Selim Kul1, İhsan Dursun1.   

Abstract

BACKGROUND: Despite improvements in treatment of ST-segment myocardial infarction (STEMI), thrombus formation in the left ventricle is still a concerning complication that may lead to systemic thromboembolism and stroke.
OBJECTIVES: To evaluate the predictive value of estimated whole blood viscosity (WBV) for left ventricular thrombus development in patients surviving an acute anterior myocardial infarction (AAMI).MATERIALS \&
METHODS: Seven hundred eighty AAMI patients who were treated percutaneously were enrolled consecutively. Serial echocardiographic examinations were performed within 24h of admission, before hospital discharge, and at 1, 3, 6 and 12 months following hospital discharge. WBV was calculated according to de Simones formula.
RESULTS: One hundred patients (12.8%) developed thrombus formation within one year following AAMI. Patients with left ventricular thrombus (LVT) had significantly higher WBV values. Supramedian values of WBV at both low (0.5 sec-1) and high (208 sec-1) shear rates were found to be an independent predictor of LVT development.
CONCLUSION: As an easily accessible parameter, WBV might be a useful predictor of LVT formation within one year following acute anterior myocardial infarction.

Entities:  

Keywords:  Blood viscosity; left ventricular thrombus; myocardial infarction; shear stress

Mesh:

Year:  2020        PMID: 32444531     DOI: 10.3233/BIR-200240

Source DB:  PubMed          Journal:  Biorheology        ISSN: 0006-355X            Impact factor:   1.875


  1 in total

1.  A case report of left ventricular thrombus formation following aggressive decongestion treatment.

Authors:  Vasiliki Chara Mystakidi; Evangelos Oikonomou; Efstratios Katsianos; Manolis Vavuranakis
Journal:  Eur Heart J Case Rep       Date:  2022-02-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.